(Q43807641)

English

Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria

scientific article published on 23 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Unfavorable inflammatory profile in adults at risk of type 2 diabetes identified by hemoglobin A1c levels according to the American Diabetes Association criteria (English)

1 reference

Europe PubMed Central

27 November 2017

type 2 diabetes

1 reference

based on heuristic

inferred from title

7

1 reference

Europe PubMed Central

27 November 2017

Maria Perticone

object named as

M Perticone

3

0 references

Francesco Andreozzi

object named as

F Andreozzi

4

0 references

author name string

T V Fiorentino

1

1 reference

Europe PubMed Central

27 November 2017

M L Hribal

2

1 reference

Europe PubMed Central

27 November 2017

A Sciacqua

5

1 reference

Europe PubMed Central

27 November 2017

F Perticone

6

1 reference

Europe PubMed Central

27 November 2017

publication date

23 September 2014

1 reference

Europe PubMed Central

27 November 2017

Acta Diabetologica

1 reference

Europe PubMed Central

27 November 2017

52

1 reference

Europe PubMed Central

27 November 2017

2

1 reference

Europe PubMed Central

27 November 2017

349-356

1 reference

Europe PubMed Central

27 November 2017

https://scigraph.springernature.com/pub.10.1007/s00592-014-0647-2

0 references

Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Pioglitazone for diabetes prevention in impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Impaired fasting glucose and impaired glucose tolerance: implications for care

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Standards of medical care in diabetes--2014

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

A1C cut points to define various glucose intolerance groups in Asian Indians

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Screening for diabetes and pre-diabetes with proposed A1C-based diagnostic criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Implications of alternative definitions of prediabetes for prevalence in U.S. adults

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

A1C between 5.7 and 6.4% as a marker for identifying pre-diabetes, insulin sensitivity and secretion, and cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study (IRAS).

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

C-reactive protein, fibrinogen, and cardiovascular disease prediction

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Leukocyte count, erythrocyte sedimentation rate, and diabetes incidence in a national sample of US adults

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

White blood cells count and incidence of type 2 diabetes in young men.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians.

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Serum C-reactive protein level and prediabetes in two Asian populations

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

One-hour postload plasma glucose levels are associated with kidney dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

The NLRP3 inflammasome: a sensor for metabolic danger?

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Pioglitazone improves glucose metabolism and modulates skeletal muscle TIMP-3-TACE dyad in type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled, mechanistic study

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

The inflammatory status score including IL-6, TNF-α, osteopontin, fractalkine, MCP-1 and adiponectin underlies whole-body insulin resistance and hyperglycemia in type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS00592-014-0647-2

21 January 2018

Identifiers

10.1007/S00592-014-0647-2

1 reference

Europe PubMed Central

27 November 2017

1 reference

Europe PubMed Central

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43807641&oldid=2113355863"